Probiotic solutions

Elogium is on the mission to improve the lives of humans and animals by using probiotics. Our proprietary probiotic strains increase food safety and animal health through fighting pathogens in farm animals.

Products in development

A probiotic feed supplement designed to reduce Campylobacter colonization in poultry. Currently at TRL 5 with promising in vitro and in vivo results, this candidate is being developed to help poultry producers comply with EU Campylobacter regulation.
A novel feed additive targeting harmful Clostridium species in poultry. Currently in proof‑of‑concept trials (TRL 3), this agent is being evaluated for its potential to prevent infections and improve flock health.
Early‑stage bioactive developed to counteract E. coli infection in swine production systems. Still in pre‑clinical development, this candidate is progressing through in vivo validation to confirm efficacy and safety.

Research partner

Elogium's research foundation is built on a strategic partnership with the University of Ljubljana, a leading European institution in environmental microbiology and bacterial interactions. Our core intellectual property, including the proprietary Bacillus subtilis strains at the heart of our technology platform, originates from breakthrough research conducted at this university. This collaboration provides access to cutting-edge facilities and world-class scientific expertise, ensuring our product development is grounded in rigorous methodology and decades of academic research excellence.